Heptanamide | CAS#628-62-6 | biochemical

MedKoo Cat#: 146194 | Name: Heptanamide

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Heptanamide is a fatty acid amide compound, commonly used as an intermediate in the synthesis of various chemical products. It has shown some potential in pharmaceutical applications, particularly in skin care and as a surfactant due to its ability to interact with cellular membranes. The compound's mechanism of action is related to its hydrophobic nature, which allows it to penetrate lipid bilayers and affect membrane fluidity, potentially influencing cell signaling. Additionally, heptanamide is being explored for its anti-inflammatory properties, though further research is needed to fully understand its therapeutic potential.

Chemical Structure

Heptanamide

CAS#628-62-6

Theoretical Analysis

MedKoo Cat#: 146194

Name: Heptanamide

CAS#: 628-62-6

Chemical Formula: C7H15NO

Exact Mass: 129.1154

Molecular Weight: 129.20

Elemental Analysis: C, 65.07; H, 11.70; N, 10.84; O, 12.38

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Heptanamide; Heptamide;

IUPAC/Chemical Name

heptanamide

InChi Key

AEDIXYWIVPYNBI-UHFFFAOYSA-N

InChi Code

1S/C7H15NO/c1-2-3-4-5-6-7(8)9/h2-6H2,1H3,(H2,8,9)

SMILES Code

CCCCCCC(N)=O

Appearance

To be determined

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 129.20 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Yoon MS, Lee YJ, Park CW, Hong JT, Baek DJ, Shin DH. In vitro anticancer evaluation of micelles containing N-(4-(2-((4-methoxybenzyl)amino)ethyl)phenyl)heptanamide, an analogue of fingolimod. Arch Pharm Res. 2020 Oct;43(10):1046-1055. doi: 10.1007/s12272-020-01276-5. Epub 2020 Oct 27. PMID: 33111965. 2: Cadot C, Laplante Y, Kamal F, Luu-The V, Poirier D. C6-(N,N-butyl-methyl- heptanamide) derivatives of estrone and estradiol as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: Chemical synthesis and biological evaluation. Bioorg Med Chem. 2007 Jan 15;15(2):714-26. doi: 10.1016/j.bmc.2006.10.055. Epub 2006 Oct 28. PMID: 17110114. 3: Hieu DT, Anh DT, Hai PT, Thuan NT, Huong LT, Park EJ, Young Ji A, Soon Kang J, Phuong Dung PT, Han SB, Nam NH. Quinazolin-4(3H)-one-Based Hydroxamic Acids: Design, Synthesis and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity. Chem Biodivers. 2019 Apr;16(4):e1800502. doi: 10.1002/cbdv.201800502. Epub 2019 Mar 21. PMID: 30653817. 4: Bhinde T, Phillips TK, Clarke SM, Arnold T, Parker JE. Phase behavior of heptanamide adsorbed on a graphite substrate. Langmuir. 2011 Jan 4;27(1):15-8. doi: 10.1021/la1041053. Epub 2010 Dec 3. PMID: 21128609. 5: Divsalar DN, Simoben CV, Schonhofer C, Richard K, Sippl W, Ntie-Kang F, Tietjen I. Novel Histone Deacetylase Inhibitors and HIV-1 Latency-Reversing Agents Identified by Large-Scale Virtual Screening. Front Pharmacol. 2020 Jun 17;11:905. doi: 10.3389/fphar.2020.00905. PMID: 32625097; PMCID: PMC7311767. 6: Abdalla MA, Win HY, Islam MT, von Tiedemann A, Schüffler A, Laatsch H. Khatmiamycin, a motility inhibitor and zoosporicide against the grapevine downy mildew pathogen Plasmopara viticola from Streptomyces sp. ANK313. J Antibiot (Tokyo). 2011 Oct;64(10):655-659. doi: 10.1038/ja.2011.68. Epub 2011 Aug 3. PMID: 21811263. 7: Son YJ, Han JW, Kang H, Seong S, Han S, Maeda S, Chikami S, Hayashi T, Hara M, Noh J. Formation and Thermal Stability of Ordered Self-Assembled Monolayers by the Adsorption of Amide-Containing Alkanethiols on Au(111). Int J Mol Sci. 2023 Feb 7;24(4):3241. doi: 10.3390/ijms24043241. PMID: 36834654; PMCID: PMC9967528. 8: Meza-Toledo SE, Yasutake-Kimoto L, Alcalá-Rentería M, Domínguez-Rodríguez MA, Jaime-Rodríguez R, Nava-Arzaluz MG, Gutiérrez-Laflor G, Peralta-Cruz J, Carvajal-Sandoval G. Synthesis of DL-hydroxybenzenamides as anticonvulsants. Arzneimittelforschung. 2008;58(3):105-10. doi: 10.1055/s-0031-1296477. PMID: 18488805. 9: Singh S, K S, Sunoj RB. Aliphatic C(sp3)-H Bond Activation Using Nickel Catalysis: Mechanistic Insights on Regioselective Arylation. J Org Chem. 2017 Sep 15;82(18):9619-9626. doi: 10.1021/acs.joc.7b01672. Epub 2017 Aug 25. PMID: 28809558. 10: Faizi S, Sumbul S, Versiani MA, Saleem R, Sana A, Siddiqui H. GC/GCMS analysis of the petroleum ether and dichloromethane extracts of Moringa oleifera roots. Asian Pac J Trop Biomed. 2014 Aug;4(8):650-4. doi: 10.12980/APJTB.4.201414B141. PMID: 25183335; PMCID: PMC4037659. 11: Jöckel J, Wendt B, Löffler M. Structural and functional comparison of agents interfering with dihydroorotate, succinate and NADH oxidation of rat liver mitochondria. Biochem Pharmacol. 1998 Oct 15;56(8):1053-60. doi: 10.1016/s0006-2952(98)00131-2. PMID: 9776318. 12: Malachy Udowo V, Unimuke TO, Louis H, Udoh II, Edet HO, Okafor PC. Enhanced sensing of bacteria biomarkers by ZnO and graphene oxide decorated PEDOT film. J Biomol Struct Dyn. 2024 Mar 18:1-14. doi: 10.1080/07391102.2024.2328740. Epub ahead of print. PMID: 38499994. 13: Kim JH, Kim JH, Oh M, Yu YS, Kim KW, Kwon HJ. N-hydroxy-7-(2-naphthylthio) heptanomide inhibits retinal and choroidal angiogenesis. Mol Pharm. 2009 Mar- Apr;6(2):513-9. doi: 10.1021/mp800178b. PMID: 19718802. 14: Huong TTL, Kim HK, Thien ND, Dung DTM, Kim JS, Kim J, Kang JS, Oanh DTK, Tung TT, Thang NQ, Anh DT, Han SB, Nam NH. Design, synthesis and biological evaluation of novel hydroxamic acid-derived histone deacetylase inhibitors bearing a 2-oxoindoline scaffold as potential antitumor agents. Bioorg Med Chem. 2025 May 1;122:118143. doi: 10.1016/j.bmc.2025.118143. Epub 2025 Mar 1. PMID: 40054131. 15: Yun HJ, Kim HJ, Kim J, Kim SY, Chang HS, Park CS, Chang HJ, Park KC. Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models. Int J Mol Sci. 2021 Jan 7;22(2):536. doi: 10.3390/ijms22020536. PMID: 33430361; PMCID: PMC7825761. 16: Lee YS, Kim SM, Kim BW, Chang HJ, Kim SY, Park CS, Park KC, Chang HS. Anti- cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells. Neoplasia. 2018 Feb;20(2):197-206. doi: 10.1016/j.neo.2017.12.003. Epub 2018 Jan 12. PMID: 29331886; PMCID: PMC5767911. 17: Tazzari V, Cappelletti G, Casagrande M, Perrino E, Renzi L, Del Soldato P, Sparatore A. New aryldithiolethione derivatives as potent histone deacetylase inhibitors. Bioorg Med Chem. 2010 Jun 15;18(12):4187-94. doi: 10.1016/j.bmc.2010.05.011. Epub 2010 May 7. PMID: 20576572. 18: Park KC, Park JH, Jeon JY, Kim SY, Kim JM, Lim CY, Lee TH, Kim HK, Lee HG, Kim SM, Kwon HJ, Suh JS, Kim SW, Choi SH. A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells. Br J Pharmacol. 2014 Nov;171(21):4820-30. doi: 10.1111/bph.12590. Epub 2014 Sep 5. PMID: 24467283; PMCID: PMC4232907. 19: Kim SM, Park KC, Jeon JY, Kim BW, Kim HK, Chang HJ, Choi SH, Park CS, Chang HS. Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer. BMC Cancer. 2015 Dec 23;15:1003. doi: 10.1186/s12885-015-1982-6. PMID: 26698299; PMCID: PMC4690331. 20: Park KC, Heo JH, Jeon JY, Choi HJ, Jo AR, Kim SW, Kwon HJ, Hong SJ, Han KS. The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release- mediated apoptosis in renal cell carcinoma cells. BMC Cancer. 2015 Jan 23;15:19. doi: 10.1186/s12885-014-1003-1. PMID: 25613585; PMCID: PMC4318161.